GH R&D Expenses
Guardant Health Inc · R&D Expenses
GH R&D Expenses
Latest reported$375.79Mperiod ending
GH TTM R&D Expenses ($26.68M → $375.79M)
TTM R&D Expenses
High-resolution chart · PNG
GH r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 375,792,000 | |
| 366,708,000 | |
| 364,191,000 | |
| 359,470,000 | |
| 356,819,000 | |
| 352,472,000 | |
| 347,753,000 | |
| 344,066,000 | |
| 350,611,000 | |
| 357,868,000 | |
| 367,194,000 | |
| 383,916,000 | |
| 390,082,000 | |
| 385,178,000 | |
| 373,807,000 | |
| 340,250,000 | |
| 311,201,000 | |
| 289,470,000 | |
| 263,221,000 | |
| 230,482,000 | |
| 195,759,000 | |
| 168,354,000 | |
| 149,862,000 | |
| 135,455,000 | |
| 123,779,000 | |
| 106,992,000 | |
| 86,292,000 | |
| 77,069,000 | |
| 66,753,000 | |
| 58,775,000 | |
| 50,714,000 | |
| 42,182,000 | |
| 35,175,000 | |
| 29,596,000 | |
| 26,681,000 |